|
The Swedish Dental and Pharmaceutical Benefits Agency ((スウェーデン語:Tandvårds- och läkemedelsförmånsverket), TLV) is an agency of the Swedish government. It was founded in 2002, and is located on Fleminggatan in Stockholm. TLV's remit is to determine which pharmaceutical products, care-related medical devices and dental care procedures shall be subsidized by the state. It also contributes to quality service and accessibility of pharmacies. The fact that a central government agency has the decision on which pharmaceutical products and medical devices are to be subsidized is partly the result of a goal to make pharmaceutical benefits equal across Sweden. It is the Government that decides, via the Ministry of Health and Social Affairs, which activities TLV shall undertake. == Decisions on pharmaceutical subsidies == Pharmaceutical companies submit applications for their products to be subsidized and covered by the high-cost threshold, which TLV then makes a decision on. TLV also reviews the pharmaceuticals already covered by the high-cost threshold to see whether or not they should remain so. TLV bases its decisions on the Pharmaceutical Benefits Act and takes into account three fundamental principles: * the cost-effectiveness principle - the cost of using a medicinal product should be reasonable from a medical, humanitarian and socioeconomic perspective * the need and solidarity principle - those with the most pressing medical needs should have more of the health care system's resources than other patient groups * the human value principle - the health care system should respect the equal value of all human life 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Swedish Dental and Pharmaceutical Benefits Agency」の詳細全文を読む スポンサード リンク
|